SCHEMBL29071996

SCHEMBL29071996

COc1ccc(Cn2c(=O)nc(C(F)(F)F)c3ccc(Br)cc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 1/20 0.46
PIK3CA P42336 1/20 0.46
MAPK8 P45983 1/20 0.43
PDE1B Q01064 4/20 0.42
P2RX4 Q99571 1/20 0.42
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
P2RX3 P56373 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
PTGS2 P35354 1/20 0.40
DCTPP1 Q9H773 2/20 0.40
CASR P41180 1/20 0.40
PDE5A O76074 1/20 0.40
PDE1A P54750 2/20 0.39
PDE1C Q14123 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29703944 0.93 PIK3R1 (0.46) PIK3R1PIK3CAMAPK8PDE1BP2RX4
SCHEMBL29393141 0.85 DCTPP1 (0.42) PIK3R1PIK3CAPDE1BP2RX4MAPT
SCHEMBL13178171 0.81 CCR2 (0.49) PIK3R1PIK3CAP2RX4MAPTKMT2A
SCHEMBL22912862 0.80 CNR1 (0.43) PIK3R1PIK3CAMAPK8MAPTKMT2A
SCHEMBL19896458 0.78 P2RX4 (0.52) PIK3R1PIK3CAMAPK8PDE1BP2RX4
SCHEMBL31283391 0.78 PDE1B (0.40) PIK3R1PIK3CAPDE1BP2RX4MAPT
SCHEMBL24307080 0.73 PDE5A (0.65) PIK3R1PIK3CAMAPK8PDE1BP2RX4
SCHEMBL31042159 0.73 PDE5A (0.65) PIK3R1PIK3CAMAPK8PDE1BP2RX4
SCHEMBL7409652 0.72 DYRK1A (0.54) MAPTP2RX3
SCHEMBL23723081 0.71 PDE1B (0.61) PIK3R1PIK3CAPDE1BP2RX4DCTPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116745269-A Dihydroquinazolin-2-one derivatives as selective cytotoxic agents for the treatment of HIV 默沙东有限责任公司 2023-09-12 CN disclosed
EP-4204413-A1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV Merck Sharp & Dohme LLC (US) 2023-07-05 EP disclosed
WO-2022125412-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME CORP. (US) 2022-06-16 WO disclosed
WO-2022046844-A1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV MERCK SHARP & DOHME CORP. (US) 2022-03-03 WO disclosed